N-(4'-Pyrazinimidoylamino-biphenyl-4-yl)-pyrazine-2-carboxamidine

ID: ALA2316315

PubChem CID: 71569231

Max Phase: Preclinical

Molecular Formula: C22H18N8

Molecular Weight: 394.44

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N=C(Nc1ccc(-c2ccc(NC(=N)c3cnccn3)cc2)cc1)c1cnccn1

Standard InChI:  InChI=1S/C22H18N8/c23-21(19-13-25-9-11-27-19)29-17-5-1-15(2-6-17)16-3-7-18(8-4-16)30-22(24)20-14-26-10-12-28-20/h1-14H,(H2,23,29)(H2,24,30)

Standard InChI Key:  COQJQPYQZUAADF-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 30 33  0  0  0  0  0  0  0  0999 V2000
   25.3559  -25.4903    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7810  -24.7896    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.3868  -24.0733    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5676  -24.0564    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   24.1443  -24.7618    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.5410  -25.4752    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.3273  -24.7482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9304  -24.0339    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.9070  -25.4491    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.7708  -22.6018    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   14.3556  -23.3084    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.7600  -24.0191    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5792  -24.0244    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.9925  -23.3131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.5858  -22.6053    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.8097  -23.3151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.2166  -24.0238    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.2200  -22.6083    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   18.0338  -24.0257    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4376  -24.7365    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2540  -24.7389    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.6652  -24.0316    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2539  -23.3205    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.4388  -23.3217    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.4794  -24.0303    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8867  -24.7401    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7031  -24.7413    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1133  -24.0335    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.7011  -23.3230    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8860  -23.3253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  5  7  1  0
  7  8  1  0
  7  9  2  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 14 16  1  0
 16 17  1  0
 16 18  2  0
 17 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 25 26  2  0
 26 27  1  0
 27 28  2  0
 28 29  1  0
 29 30  2  0
 30 25  1  0
 22 25  1  0
 28  8  1  0
M  END

Associated Targets(Human)

HepG2 (196354 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PA-1 (704 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-15 (51914 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H522 (44358 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
T47D (39041 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

COS-1 (266 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Rattus norvegicus (775804 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 394.44Molecular Weight (Monoisotopic): 394.1654AlogP: 3.81#Rotatable Bonds: 5
Polar Surface Area: 123.32Molecular Species: NEUTRALHBA: 6HBD: 4
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.80CX LogP: 1.73CX LogD: 1.73
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.30Np Likeness Score: -0.65

References

1. Arya S, Kumar N, Roy P, Sondhi SM..  (2013)  Synthesis of amidine and bis amidine derivatives and their evaluation for anti-inflammatory and anticancer activity.,  59  [PMID:23202484] [10.1016/j.ejmech.2012.10.046]

Source